China

News

CARSgen Therapeutics has claimed approval in China for gastric cancer therapy satri-cel, the first CAR-T to be cleared for a solid tumour.

Oncology

National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.

Oncology

The next leaders in oncology will be the ones built to adapt in real time.

News

GSK has partnered Sino Biopharm to make the most of the Chinese launch of hepatitis B drug bepirovirsen, currently under NMPA review.

News

Pfizer has claimed its first regulatory approval for a GLP-1 agonist in obesity, getting a green light in China for Sciwind-sourced ecnoglutide.

Market Access

JPM 2026 signalled genuine recovery – but not the kind the industry has historically celebrated.